CD274 and cancer: By contrast, chronic PARP inhibition leads to sustained DNA damage that promotes several cellular mechanisms, such as increasing genomic instability, immune pathway activation, and programmed death-ligand 1 (PD-L1) expression on cancer cells, which might promote responsiveness to ICIs.